Update on Chronic Myelogenous Leukemia (CML)
Part of From the 2010 American Society of Hematology (ASH) Annual Meeting
Listen Now
Topics Covered
- Overview of CML
- New Treatment Approaches Reported at ASH
- How Clinical Trials Contribute to Treatment Options
- Doctor-Patient Communication
- Understanding the Important Role of Adherence: Taking Your Pills on Schedule
- Quality-of-Life Concerns
- Questions for Our Panel of Speakers
Our Panel of Experts
-
Michael J. Mauro, MD
- Associate Professor, Center for Hematologic Malignancies, Oregon Cancer Institute, Oregon Health & Science University
-
Neil P. Shah, MD, PhD
- Assistant Professor, Division of Hematology/Oncology, University of California San Francisco
-
Richard Dickens, MSW
- Blood Cancers Program Coordinator, Mind/Body/Spirit Project Coordinator, CancerCare
Workshop Date
This workshop was originally recorded on April 7, 2011.